PCG
PFE icon

Prosperity Consulting Group’s Pfizer PFE Stock Holding History

Prosperity Consulting Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Sell
44,889
-5,330
-11% -$139K 0.04% 250
2026
Q1 		$1.41M Sell
50,219
-11,754
-19% -$313K 0.06% 197
2025
Q4 		$1.54M Sell
61,973
-324
-0.5% -$8.17K 0.07% 194
2025
Q3 		$1.59M Buy
62,297
+8,521
+16% +$210K 0.08% 193
2025
Q2 		$1.3M Buy
53,776
+1,893
+4% +$44.1K 0.1% 189
2025
Q1 		$1.31M Sell
51,883
-6,691
-11% -$175K 0.1% 187
2024
Q4 		$1.55M Sell
58,574
-16,959
-22% -$460K 0.12% 174
2024
Q3 		$2.19M Buy
75,533
+18,253
+32% +$532K 0.17% 140
2024
Q2 		$1.6M Sell
57,280
-8,617
-13% -$237K 0.22% 107
2024
Q1 		$1.83M Buy
65,897
+19,431
+42% +$539K 0.23% 104
2023
Q4 		$1.34M Sell
46,466
-2,137
-4% -$64.6K 0.45% 52
2023
Q3 		$1.61M Buy
48,603
+7,090
+17% +$251K 0.74% 33
2023
Q2 		$1.52M Sell
41,513
-1,836
-4% -$71.5K 0.94% 27
2023
Q1 		$1.77M Sell
43,349
-2,246
-5% -$97K 1.12% 26
2022
Q4 		$2.34M Buy
45,595
+208
+0.5% +$9.97K 1.56% 18
2022
Q3 		$1.99M Buy
45,387
+9,061
+25% +$440K 1.63% 17
2022
Q2 		$1.91M Sell
36,326
-181
-0.5% -$9.22K 1.65% 16
2022
Q1 		$1.89M Sell
36,507
-46
-0.1% -$2.39K 1.4% 21
2021
Q4 		$1.97M Buy
+36,553
New +$1.81M 1.48% 20

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Prosperity Consulting Group's PFE Position: Q2 2026 in Review

Prosperity Consulting Group reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $139K and leaving 44,889 shares worth $1.08M. The position accounts for 0.04% of the portfolio, ranked #250.

Prosperity Consulting Group first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.34M in Q4 2022. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Prosperity Consulting Group held 44,889 shares of Pfizer worth $1.08M as of Q2 2026.
  • Prosperity Consulting Group sold 5,330 Pfizer shares in Q2 2026, an estimated $139K.
  • Pfizer made up 0.04% of Prosperity Consulting Group's portfolio in Q2 2026, its #250 holding.
  • Prosperity Consulting Group first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Prosperity Consulting Group's Pfizer position peaked at $2.34M in Q4 2022.
  • 2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.